Imberti, Jacopo Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 6.289
NA - Nord America 6.129
EU - Europa 2.825
SA - Sud America 947
OC - Oceania 256
AF - Africa 126
Continente sconosciuto - Info sul continente non disponibili 2
Totale 16.574
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.929
SG - Singapore 2.060
CN - Cina 1.883
IT - Italia 942
BR - Brasile 740
HK - Hong Kong 725
VN - Vietnam 606
GB - Regno Unito 354
FI - Finlandia 305
KR - Corea 299
DE - Germania 271
AU - Australia 254
SE - Svezia 229
RU - Federazione Russa 194
BD - Bangladesh 168
FR - Francia 138
ID - Indonesia 99
IN - India 91
CA - Canada 89
AR - Argentina 78
MX - Messico 74
NL - Olanda 60
IQ - Iraq 40
JP - Giappone 40
TR - Turchia 40
AE - Emirati Arabi Uniti 38
PL - Polonia 38
ZA - Sudafrica 38
AT - Austria 35
PK - Pakistan 35
UA - Ucraina 33
BG - Bulgaria 31
LT - Lituania 31
CO - Colombia 30
ES - Italia 30
EC - Ecuador 27
UZ - Uzbekistan 22
MA - Marocco 20
VE - Venezuela 20
CL - Cile 19
EG - Egitto 18
IE - Irlanda 18
KE - Kenya 16
RS - Serbia 16
TH - Thailandia 16
AZ - Azerbaigian 13
BE - Belgio 13
MY - Malesia 13
SA - Arabia Saudita 13
CZ - Repubblica Ceca 12
RO - Romania 12
DZ - Algeria 11
PY - Paraguay 11
TW - Taiwan 11
TN - Tunisia 10
BO - Bolivia 9
JO - Giordania 9
OM - Oman 9
KZ - Kazakistan 8
HU - Ungheria 7
NP - Nepal 7
PE - Perù 7
PH - Filippine 7
PT - Portogallo 7
AL - Albania 6
CH - Svizzera 6
GE - Georgia 6
TT - Trinidad e Tobago 6
CU - Cuba 5
DO - Repubblica Dominicana 5
IL - Israele 5
IR - Iran 5
UY - Uruguay 5
BY - Bielorussia 4
CR - Costa Rica 4
HR - Croazia 4
JM - Giamaica 4
SK - Slovacchia (Repubblica Slovacca) 4
SV - El Salvador 4
CY - Cipro 3
GT - Guatemala 3
KG - Kirghizistan 3
LK - Sri Lanka 3
LU - Lussemburgo 3
LV - Lettonia 3
MD - Moldavia 3
NO - Norvegia 3
PS - Palestinian Territory 3
SN - Senegal 3
BA - Bosnia-Erzegovina 2
CW - ???statistics.table.value.countryCode.CW??? 2
DK - Danimarca 2
EE - Estonia 2
ET - Etiopia 2
GR - Grecia 2
HN - Honduras 2
LB - Libano 2
MT - Malta 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
Totale 16.553
Salva come PNG Salva come JPEG
Città #
Singapore 1.282
Santa Clara 956
Hefei 931
Ashburn 807
Hong Kong 717
San Jose 615
Seoul 299
Helsinki 246
Fairfield 237
Beijing 235
Chandler 220
London 212
Ho Chi Minh City 196
Nyköping 180
New York 179
Council Bluffs 171
Perth 167
Los Angeles 161
The Dalles 153
Hanoi 133
Chicago 110
Milan 101
Dallas 100
Houston 99
Woodbridge 95
Munich 90
Bologna 83
Seattle 83
Wilmington 78
Buffalo 72
Cambridge 72
Lauterbourg 71
São Paulo 71
Jakarta 69
Shanghai 67
Rome 65
Modena 53
Kent 52
Moscow 51
Salt Lake City 47
San Diego 47
Mexico City 40
Sydney 40
Lappeenranta 39
Boardman 37
Princeton 37
Frankfurt am Main 36
Orem 36
Ann Arbor 34
Da Nang 33
Tokyo 33
Haiphong 29
Sofia 29
Toronto 29
Atlanta 26
Montreal 26
Warsaw 26
Schiffdorf 25
Southend 25
Johannesburg 24
Amsterdam 23
Redondo Beach 23
Nuremberg 21
Turin 21
Tashkent 20
Denver 19
Dublin 19
Guangzhou 19
Rio de Janeiro 19
Turku 19
Vienna 19
Naples 18
Parma 18
Stockholm 18
Columbus 17
Düsseldorf 17
Memphis 17
Baghdad 16
Portsmouth 16
Brooklyn 15
Campinas 15
Chennai 15
Hải Dương 15
Kilburn 15
Belo Horizonte 14
Biên Hòa 14
Elk Grove Village 14
Boston 13
Melbourne 13
Phoenix 13
Porto Alegre 13
Belgrade 12
Curitiba 12
Miami 12
Mumbai 12
Nairobi 12
Tampa 12
Ankara 11
Baku 11
Brasília 11
Totale 10.910
Salva come PNG Salva come JPEG
Nome #
Atrial Fibrillation in the Setting of Acute Pneumonia: Not a Secondary Arrhythmia 495
Impact of COVID-19 pandemic on the clinical activities related to arrhythmias and electrophysiology in Italy: results of a survey promoted by AIAC (Italian Association of Arrhythmology and Cardiac Pacing) 316
Device-detected atrial high rate episodes and the risk of stroke/thrombo-embolism and atrial fibrillation incidence: a systematic review and meta-analysis 302
Percutaneous pericardiocentesis for pericardial effusion: predictors of mortality and outcomes 285
DIGItal Health Literacy after COVID-19 Outbreak among Frail and Non-Frail Cardiology Patients: The DIGI-COVID Study 274
2022 ESC Guidelines for the management of ventricular arrhythmias and sudden cardiac death: an important focus on a multidisciplinary approach to a tailored diagnostic and therapeutic work-up|Linee guida europee 2022 su aritmie ventricolari e morte cardiaca improvvisa: un importante impulso a un impegno multidisciplinare in campo diagnostico e terapeutico per un’accurata personalizzazione dell’approccio clinico 252
Cardioversion of recent-onset atrial fibrillation: current evidence, practical considerations, and controversies in a complex clinical scenario 252
Asymptomatic vs. symptomatic atrial fibrillation: Clinical outcomes in heart failure patients 237
Long-term outcomes of postoperative atrial fibrillation following non cardiac surgery: A systematic review and metanalysis 233
The 2024 ESC guidelines on atrial fibrillation: essential updates for everyday clinical practice 229
Remote monitoring and telemedicine in heart failure: implementation and benefits 219
Atrial cardiomyopathy: An entity of emerging interest in the clinical setting 217
Progression of Atrial Fibrillation after Cryoablation 217
Comparative analysis of level of evidence and class of recommendation for 50 clinical practice guidelines released by the European Society of Cardiology from 2011 to 2022 215
Atrial fibrillation burden: Stepping beyond the categorical characterization 211
Atrial fibrillation and remote monitoring through cardiac implantable electronic devices in heart failure patients 199
Red cell distribution width: a routinely available biomarker with important clinical implications in patients with atrial fibrillation 199
What do we do about atrial high rate episodes? 198
Detection of subclinical atrial fibrillation with cardiac implanted electronic devices: What decision making on anticoagulation after the NOAH and ARTESiA trials? 194
A systematic review and meta-analysis on oncological radiotherapy in patients with a cardiac implantable electronic device: Prevalence and predictors of device malfunction in 3121 patients 193
Female sex and stroke in atrial fibrillation: an intriguing relationship 188
Low Occurrence of Infections and Death in a Real-World Cohort of Patients with Cardiac Implantable Electronic Devices 186
Single-lead VDD pacing: a literature review on short-term and long-term performance 184
Atrial high-rate episodes: clinical significance, prognostic impact and clinical management 184
Short and long-term outcomes after cardiac surgery in Jehovah's Witnesses patients: a case-control study 183
Managing atrial fibrillation: the need for an individualized approach even in the emergency department 182
Radiotherapy-induced malfunctions of cardiac implantable electronic devices in cancer patients 180
Clinical significance and prognostic value of right bundle branch block in permanent pacemaker patients 179
Cardiac Surgery in Jehovah's Witnesses Patients and Association With Peri-Operative Outcomes: A Systematic Review and Meta-Analysis 175
Anticoagulation to prevent ischemic stroke in patients with atrial fibrillation: a complex scenario including underdiagnosis, undertreatment or underdosing of oral anticoagulants 175
Adherence to the “Atrial fibrillation Better Care” (ABC) pathway in patients with atrial fibrillation and cancer: A report from the ESC-EHRA EURObservational Research Programme in atrial fibrillation (EORP-AF) General Long-Term Registry 174
Cognitive impairment in patients with atrial fibrillation: Implications for outcome in a cohort study 174
Clinical Factors Associated with Atrial Fibrillation Detection on Single-Time Point Screening Using a Hand-Held Single-Lead ECG Device 171
Cardiovascular Reasons for Access to a Tertiary Oncological Emergency Service: The CARILLON Study 170
Atrial cardiomyopathy: a derangement in atrial volumes, geometry, function, and pathology with important clinical implications 167
Atrial fibrillation in pneumonia: what clinical implications at long-term? 162
Ventricular and Atrial Remodeling after Transcatheter Edge-to-Edge Repair: A Pilot Study 161
Cardiac resynchronization therapy (CRT) nonresponders in the contemporary era: A state-of-the-art review 159
Factors Associated with Progression of Atrial Fibrillation and Impact on All-Cause Mortality in a Cohort of European Patients 158
Atrial fibrillation screening: Great debate on which approach to apply, which tools to use and which population to target 158
Features of Clinical Complexity in European Patients With Atrial Fibrillation: A Report From a European Observational Prospective AF Registry 156
Atrial fibrillation in vascular surgery: a systematic review and meta-analysis on prevalence, incidence and outcome implications 154
Catheter ablation as first-line treatment for paroxysmal atrial fibrillation: A systematic review and meta-analysis 153
Systematic review and meta-Analysis on the impact on outcomes of device algorithms for minimizing right ventricular pacing 151
Remote multiparametric monitoring and management of heart failure patients through cardiac implantable electronic devices 150
Comparing atrial fibrillation guidelines: Focus on stroke prevention, bleeding risk assessment and oral anticoagulant recommendations 150
Quantification of Myocardial Contraction Fraction with Three-Dimensional Automated, Machine-Learning-Based Left-Heart-Chamber Metrics: Diagnostic Utility in Hypertrophic Phenotypes and Normal Ejection Fraction 149
Performance of HAS-BLED and DOAC scores to predict major bleeding events in atrial fibrillation patients treated with direct oral anticoagulants: A report from a prospective European observational registry 148
From meta-analysis to the individual patient with atrial fibrillation and coronary artery disease: the complexity of antithrombotic treatment in real-world clinical practice and the need for a tailored approach 146
Clinical decisions for appropriate management of patients with atrial fibrillation 144
Cardiac resynchronization therapy: variations across Europe in implant rates and types of implanted devices 143
Atrial High-Rate Episodes Detected by Cardiac Implantable Electronic Devices: Dynamic Changes in Episodes and Predictors of Incident Atrial Fibrillation 143
Implantable cardioverter defibrillators and devices for cardiac resynchronization therapy: what perspective for patients’ apps combined with remote monitoring? 142
Atrial Fibrillation Ablation in Patients Recently Hospitalized for Worsening Heart Failure: Need for Individualized Decision-Making 139
Incidence and Predictors of Infections and All-Cause Death in Patients with Cardiac Implantable Electronic Devices: The Italian Nationwide RI-AIAC Registry 136
Atrial fibrillation and HIV: a new association requiring pathophysiological and outcome studies 135
Driving restriction in patients with cardiac implantable electronic devices: an overview of worldwide regulations 134
Atrial Fibrillation Better Care Pathway Adherent Care Improves Outcomes in Chinese Patients With Atrial Fibrillation 133
Inhibition of lysyl oxidase stimulates TGF-β signaling and metalloproteinases-2 and -9 expression and contributes to the disruption of ascending aorta in rats: protection by propylthiouracil 132
Atrial high rate episodes as a marker of atrial cardiomyopathy: In the quest of the Holy Grail. Author's reply 132
Current status of reimbursement practices for remote monitoring of cardiac implantable electrical devices across Europe 130
Digital literacy as a potential barrier to implementation of cardiology tele-visits after COVID-19 pandemic: The INFO-COVID survey 130
Drug management of atrial fibrillation in light of guidelines and current evidence: an Italian Survey on behalf of Italian Association of Arrhythmology and Cardiac Pacing 127
Clinical Profile, Arrhythmias, and Adverse Cardiac Outcomes in Emery–Dreifuss Muscular Dystrophies: A Systematic Review of the Literature 126
The epidemiology and mortality of patients with atrial fibrillation: a complex landscape 125
Yield of diagnosis and risk of stroke with screening strategies for atrial fibrillation: a comprehensive review of current evidence 125
Atrial fibrillation post-coronary or cardiac surgery: A transient inflammation-related event or the expression of a pre-existing arrhythmogenic atrial substrate? 123
Atrial fibrillation, comorbidities, stroke, and mortality in real‑world clinical practice 122
Performance of a multi-sensor implantable defibrillator algorithm for heart failure monitoring in the presence of atrial fibrillation 120
A call to action: The need to apply guidelines recommendations with ABC or SOS to improve stroke prevention and cardiovascular outcomes in patients with atrial fibrillation 120
Echocardiographic Left Ventricular Mass Assessment: Correlation between 2D-Derived Linear Dimensions and 3-Dimensional Automated, Machine Learning-Based Methods in Unselected Patients 119
Left and right atrial echocardiographic parameters and outcome in patients with atrial fibrillation 114
Therapeutic effects of sodium–glucose cotransporter 2 inhibitors in patients with heart failure with preserved ejection fraction: From outcome improvement to potentially favourable influences on atrial fibrillation burden, atrial fibrillation progression and atrial cardiomyopathy 114
Antiarrhythmic drugs in the era of atrial fibrillation ablation 114
Optimal Medical Therapy for Heart Failure and Integrated Care in Patients With Atrial Fibrillation: A Report From the ESC-EHRA EORP Atrial Fibrillation Long-Term General Registry 113
Peripheral artery disease, antithrombotic treatment and outcomes in European and Asian patients with atrial fibrillation: analysis from two prospective observational registries 113
The challenge to improve knowledge on the interplay between subclinical atrial fibrillation, atrial cardiomyopathy, and atrial remodeling 112
Screening for atrial fibrillation: different approaches targeted to reduce ischemic stroke 111
Poor adherence to guideline-directed anticoagulation in elderly Chinese patients with atrial fibrillation: a report from the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry 110
4S-AF scheme and ABC pathway guided management improves outcomes in atrial fibrillation patients 109
Multimorbidity in atrial fibrillation: A call for integrated patient-centered care 106
Oral anticoagulation for atrial fibrillation and high risk of bleeding in daily practice: What clinical considerations? 106
The search for a gold standard to clinically diagnose and monitor atrial cardiomyopathy 106
Letter by Imberti et al Regarding Article, "DREAM-ICD-II Study" 104
Mobile health technology in atrial fibrillation 104
Patterns of comorbidities, clinical course, and impact of the ABC Pathway for Integrated Care in patients with atrial fibrillation: a report from the prospective Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) Registry 104
Procedural complications in patients undergoing catheter ablation for atrial fibrillation: Let's talk about sex 103
Effectiveness of atrial fibrillation ablation in heart failure across the entire spectrum of left ventricular ejection fraction 100
Detection and management of postoperative atrial fibrillation after coronary artery bypass grafting or non-cardiac surgery: a survey by the AF-SCREEN International Collaboration 99
The burden of atrial fibrillation in patients with preserved or mildly reduced heart failure: a call to action for detecting atrial fibrillation and improving outcome 98
Provision of care in clinical cardiac electrophysiology during and after the COVID-19 pandemic: An open challenge for health care systems 98
Updating a simple clinical score predicting incident atrial fibrillation: The C2HEST score or more (mC2HEST)? 98
Access to implantable cardioverter defibrillator therapy within and across countries: the barriers still persist 95
Remote monitoring of cardiac implantable electronic devices: from data to clinical actions 95
Length of hospital stay for elective electrophysiological procedures: a survey from the European Heart Rhythm Association 93
Atrial fibrillation screening: The importance of the patient perspective 90
Cardiovascular-kidney-metabolic domains and impact on antithrombotic treatment, integrated care and clinical outcomes in patients with atrial fibrillation: results from a prospective European registry 87
Dronedarone for the treatment of atrial fibrillation with concomitant heart failure and preserved or mildly reduced ejection fraction: closer to Ithaca after a long odyssey? 84
New Perspectives on Risk Stratification and Treatment in Patients with Atrial Fibrillation: An Analysis of Recent Contributions on the Journal of Cardiovascular Disease and Development 81
Real-World Use of ARNI Within GDMT in HFrEF Patients with and Without Atrial Fibrillation: A Retrospective Analysis of Cardiac and Renal Functions and Clinical Outcomes 78
Totale 15.583
Salva come PNG Salva come JPEG
Categoria #
all - tutte 76.149
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 76.149
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202127 0 0 0 0 0 0 0 0 0 0 0 27
2021/2022667 52 76 14 24 25 43 18 38 68 42 126 141
2022/2023835 88 92 81 50 64 110 29 90 94 19 73 45
2023/20241.088 18 55 67 110 240 141 88 132 18 37 57 125
2024/20254.367 74 58 264 230 616 564 407 263 420 285 633 553
2025/20269.198 679 430 805 1.129 975 476 1.306 537 1.128 787 667 279
Totale 16.733